The lawsuit, spearheaded by the Rosen Law Firm, centers on claims that the definitive proxy statement issued in May 2025 contained material omissions regarding the firm’s true valuation. Plaintiffs allege that the merger was presented as an arm’s-length transaction while failing to disclose Executive Chairman Foley’s personal interest in an expedited sale. Furthermore, the complaint asserts that the board withheld information regarding Bank of America Securities’ valuations of superior alternatives and neglected to reveal significant ties between Foley and the company’s financial and legal advisors. Investors affected include those who sold shares between May 13 and August 26, 2025, or those who held stock as of the May 9, 2025, record date. While no class has been certified yet, those wishing to participate as lead plaintiffs must file motions with the court before the November deadline. Prospective class members are not required to take immediate action to retain their rights to potential future recoveries but may choose their own legal representation.
Investors Face November Deadline in Dun & Bradstreet Securities Suit
Investors who held or sold Dun & Bradstreet Holdings common stock during 2025 have until November 10, 2026, to seek lead plaintiff status in a securities class action lawsuit. The litigation targets alleged misrepresentations surrounding the company's $9.15-per-share merger with affiliates of Clearlake Capital Group.




Comments (0)
No comments yet. Be the first!